Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Immunology (2)
Nature Medicine (2)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (3)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Immunology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: Alina Boesteanu Clear advanced filters

Thymic selection of CD4⁺CD25⁺ regulatory T cells induced by an agonist self-peptide

Martha S. Jordan
Alina Boesteanu
Andrew J. Caton
Research01 Apr 2001
Nature Immunology

Volume: 2, P: 301-306
Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Joseph A. Fraietta
Simon F. Lacey
J. Joseph Melenhorst
Amendments and Corrections05 Feb 2021
Nature Medicine

Volume: 27, P: 561
The microRNA miR-155 controls CD8⁺ T cell responses by regulating interferon signaling

The roles of individual microRNAs in the CD8⁺ T cell response remain mostly unexplored. Katsikis and colleagues show that miR-155 regulates type I interferon responsiveness and CD8⁺ T cell responses to pathogens in vivo.

Donald T Gracias
Erietta Stelekati
Peter D Katsikis
Research21 Apr 2013
Nature Immunology

Volume: 14, P: 593-602
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

An IL-6/STAT3 signature and memory CD8 T cell subset in preinfusion chimeric antigen receptor–expressing T cells associate with response in patients with high-risk chronic lymphocytic leukemia.

Joseph A. Fraietta
Simon F. Lacey
J. Joseph Melenhorst
Research30 Apr 2018
Nature Medicine

Volume: 24, P: 563-571